Article History
Accepted: 24 February 2022
First Online: 7 July 2022
Declarations
:
: EOB discloses research support from Juvenile Diabetes Research Foundation and DexCom, Inc. KD discloses research support from Novo Nordisk, Sanofi, Viacyte, Abbott, consulting with Eli Lilly, Novo Nordisk, Boehringer-Ingelheim, and Tolerion, and honorarium from UptoDate, Medscape, and Elsevier. EF discloses research support with DexCom Inc.
Free to read: This content has been made available to all.